No results for ‘’
Panacea Biotec Ltd
₹397.65
(2.32%)
Mon, 14 Sept 2026, 09:33 pm
Health Technology
Pharmaceuticals: Major
24.5KPanacea Biotec Shareholding
| Shareholders | MAR 2026 | DEC 2025 | SEPT 2025 | JUN 2025 | MAR 2025 |
|---|---|---|---|---|---|
| Promoters | 72.48 | 72.48 | 72.48 | 72.48 | 72.48 |
| FII | 1.60 | 1.36 | 1.06 | 0.78 | 1.16 |
| DII | 1.97 | 1.85 | 1.81 | 1.52 | 1.49 |
| Public | 23.96 | 24.30 | 24.66 | 25.22 | 24.86 |
| Government | 0 | 0 | 0 | 0 | 0 |
Panacea Biotec Ltd Shareholding Pattern
The Panacea Biotec Ltd shareholding pattern provides detailed insights into how ownership of the company is distributed among promoters, FIIs, DIIs, public investors, and government entities. Tracking the Panacea Biotec Ltd shareholding structure helps investors understand institutional confidence, promoter commitment, and overall market sentiment.
Panacea Biotec Ltd (NSE: PANACEABIO, BSE: 531349) operates in the Health technology sector and Pharmaceuticals: major industry. Monitoring the Panacea Biotec Ltd shareholding pattern regularly allows investors to analyze ownership trends and make informed investment decisions.
Panacea Biotec Ltd Shareholding Pattern (Latest)
The latest Panacea Biotec Ltd shareholding for Mar 2026 is:
- Promoters: 72.48%
- FII: 1.60%
- DII: 1.97%
- Public: 23.96%
- Government: 0%
Promoter holding in Panacea Biotec Ltd remains stable, reflecting consistent long-term commitment.
Panacea Biotec Ltd Promoter Holding Trend
Promoter shareholding plays a crucial role in evaluating management confidence in Panacea Biotec Ltd.
- Mar 2026: 72.48%
- Dec 2025: 72.48%
- Sept 2025: 72.48%
- Jun 2025: 72.48%
- Mar 2025: 72.48%
Promoter stake remains largely stable, showing consistent ownership structure.
Panacea Biotec Ltd FII Shareholding Trend
Foreign Institutional Investors (FIIs) reflect global investor sentiment toward Panacea Biotec Ltd.
- Mar 2026: 1.60%
- Dec 2025: 1.36%
- Sept 2025: 1.06%
- Jun 2025: 0.78%
- Mar 2025: 1.16%
FII holding in Panacea Biotec Ltd has increased recently, indicating rising foreign investor interest.
Panacea Biotec Ltd DII Shareholding Trend
Domestic Institutional Investors (DIIs) include mutual funds, banks, and insurance companies.
- Mar 2026: 1.97%
- Dec 2025: 1.85%
- Sept 2025: 1.81%
- Jun 2025: 1.52%
- Mar 2025: 1.49%
DII stake in Panacea Biotec Ltd has increased over time, indicating growing domestic institutional confidence.
Panacea Biotec Ltd Public Shareholding Trend
Public shareholding represents retail and non-institutional investors.
- Mar 2026: 23.96%
- Dec 2025: 24.30%
- Sept 2025: 24.66%
- Jun 2025: 25.22%
- Mar 2025: 24.86%
Public holding remains stable with consistent retail participation.
Panacea Biotec Ltd Government Holding
Government holding in Panacea Biotec Ltd currently stands at 0%.
Panacea Biotec Ltd operates without significant government ownership.
Panacea Biotec Ltd Shareholding Analysis Summary
The Panacea Biotec Ltd shareholding pattern highlights the ownership structure and investor confidence in the company. Stable promoter holdings combined with institutional participation often indicate strong fundamentals and long-term growth potential.
Panacea Biotec Ltd shows strong promoter and domestic institutional confidence, which is positive for long-term investors.
Regular monitoring of the Panacea Biotec Ltd shareholding helps investors understand market confidence, institutional activity, and potential future stock movements.